What Is CCHD Screening? Newborn Pulse Oximetry

CCHD screening is a simple, painless test performed on newborns to detect critical congenital heart defects before a baby leaves the hospital. It uses a small light sensor clipped to the baby’s skin to measure oxygen levels in the blood. About 2 in every 1,000 babies are born with a critical heart defect, and many of these defects aren’t visible at birth. Without screening, some babies go home looking healthy but develop life-threatening complications within days.

What the Test Measures

The screening uses pulse oximetry, the same technology behind the finger clip you might wear at a doctor’s office. A small sensor wraps around the baby’s right hand and one foot, shining a light through the skin to measure how much oxygen the blood is carrying. The whole process takes just a few minutes and doesn’t involve needles or blood draws.

The reason it checks two locations is important. The right hand reflects oxygen levels in blood heading to the upper body (before it passes through a specific blood vessel called the ductus arteriosus), while the foot reflects oxygen levels in blood heading to the lower body (after passing through that vessel). In a healthy heart, these readings should be very close. A significant gap between the two suggests blood may not be flowing through the heart and lungs the way it should.

When Screening Happens

The test is typically performed after the baby is 24 hours old, or shortly before discharge if the hospital stay is shorter than that. Waiting at least 24 hours reduces the chance of a misleading result, since oxygen levels naturally fluctuate during the first hours of life as the newborn’s circulation adjusts to breathing air.

What Counts as a Pass or Fail

A baby passes the screen if oxygen saturation is 95% or higher in either the right hand or the foot, and the difference between the two readings is 3% or less. Those numbers indicate the heart is effectively oxygenating and circulating blood.

If the initial reading falls below that threshold, or if the gap between the hand and foot is greater than 3%, the test is repeated. The baby gets up to three attempts, each separated by one hour. A baby who doesn’t meet the passing criteria after three rounds is considered to have a positive (failed) screen and needs further evaluation, typically an echocardiogram, which is an ultrasound of the heart that gives doctors a detailed picture of its structure.

Which Heart Defects It Detects

The screening targets 12 specific critical congenital heart defects. These are structural problems where the heart or its major blood vessels didn’t form correctly during pregnancy, and they all share one characteristic: they reduce the amount of oxygen reaching the body. The targeted conditions include:

  • Hypoplastic left heart syndrome, where the left side of the heart is severely underdeveloped
  • Transposition of the great arteries, where the two main arteries leaving the heart are switched
  • Tetralogy of Fallot, a combination of four structural defects that reduce blood flow to the lungs
  • Coarctation of the aorta, a narrowing of the body’s main artery
  • Pulmonary atresia, where the valve controlling blood flow to the lungs doesn’t form properly
  • Total anomalous pulmonary venous return, where oxygen-rich blood from the lungs routes to the wrong chamber
  • Truncus arteriosus, tricuspid atresia, interrupted aortic arch, Ebstein anomaly, double outlet right ventricle, and single ventricle defects

Because all of these conditions lower oxygen in the blood, pulse oximetry can flag them even when a baby looks pink and healthy to the naked eye. The screen can also incidentally catch other non-cardiac conditions that cause low oxygen, such as certain lung problems or infections.

What the Screen Can Miss

Pulse oximetry screening catches roughly 80% of critical heart defects. That means about 1 in 5 babies with a critical defect will pass the screen. False negatives happen because some heart defects don’t cause noticeably low oxygen levels at the time of testing. For example, coarctation of the aorta may not produce a measurable oxygen drop in the first day or two of life, since the ductus arteriosus (a fetal blood vessel that normally closes after birth) can temporarily compensate for the narrowing.

This is why a passing screen doesn’t guarantee the heart is perfectly normal. It’s a strong initial check, but parents should watch for warning signs in the first couple of weeks: rapid or labored breathing, poor feeding, unusual sleepiness, bluish tint to the lips or skin, and failure to gain weight. A passing result is considered presumptive, meaning it’s a good sign but not a definitive diagnosis of a healthy heart.

Screening Mandates Across the U.S.

By 2018, all 50 states and the District of Columbia had implemented CCHD screening mandates, making it one of the most universally adopted newborn tests in the country. California is a notable exception in how its mandate works: screening is offered to all newborns but is not technically required by law, though hospitals must report results to state agencies.

How strictly states enforce screening protocols varies considerably. Only 10 states require hospitals to follow the nationally endorsed screening protocol. Another 16 reference the protocol in training materials but don’t mandate it. The remaining 24 states require screening but leave the specific procedures up to individual hospitals. States without reporting mandates tend to have less consistent implementation, which means the quality of screening can differ depending on where a baby is born.

What Happens After a Failed Screen

A failed screen doesn’t automatically mean a baby has a heart defect. It means oxygen levels were lower than expected and the baby needs a closer look. The next step is an echocardiogram, which uses sound waves to create a real-time image of the heart’s chambers, valves, and blood vessels. This test is also painless and usually takes 30 to 45 minutes.

If the echocardiogram reveals a structural problem, the baby is referred to a pediatric cardiologist. Treatment depends entirely on the specific defect. Some conditions require surgery within the first days or weeks of life, while others can be managed with medication or monitored over time. The critical advantage of catching these defects early, before a baby becomes visibly sick, is that it allows medical teams to intervene in a controlled setting rather than responding to an emergency.

For babies whose echocardiogram comes back normal, the low oxygen reading may have been caused by something else entirely, such as a transitional breathing issue common in the first day of life. In these cases, the medical team will address whatever underlying cause they find, and the baby typically does well.